Skip to main content
polymyalgia rheumatica

polymyalgia rheumatica

DiseaseWikipedia

Search complete. 63 mentions across 13 episodes found for "polymyalgia rheumatica".

Oct 31, 2026

Richard HorowitzGUEST
15:14
So you've got to look at that full multisystemic picture when you're trying to differentiate, for example, a rash that's a ringworm or a cellulitis versus something that's a Lyme rash where you now have these multisystemic manifestations.
Kerry GelbHOST
15:25
How about like PMR, polymyalgia rheumatica? Sometimes that pain will migrate.
Richard HorowitzGUEST
15:32
So I've only seen a couple of cases in my lifetime.
Richard HorowitzGUEST
15:34
I've been doing medicine for 42 years with 13,000 people.
Richard HorowitzGUEST
15:39
Usually with PMR, the SED rate is going to be 80, 90, 100, right? I mean, you get this massive inflammatory response.
Richard HorowitzGUEST
15:46
I've only seen a handful of cases of it.
Richard HorowitzGUEST
15:48
And in a lot of cases, there might have been some overlapping autoimmune manifestations.
Richard HorowitzGUEST
15:54
I'd have to do a search for you on that one.
Jack CushHOST
0:19
a special edition since it's the day before Halloween, and I'm Jack Cush wearing a goofy Halloween cap.
Jack CushHOST
0:28
This week on the podcast, new guidelines for PMR, certainty about good and bad beverages in gout, mixed results, and Sjogren's.
Jack CushHOST
0:40
Non-lupus drugs save lupus lives and big hips sink ships in psoriatic arthritis.
Jack CushHOST
0:48
If you can decipher that, you'll know everything about rheumatology.
Jack CushHOST
0:54
At the top.
Jack CushHOST
0:55
Novartis announced this past week that the European Commission has approved Cosentix secukinumab for use in adults with polymyalgia rheumatica.
Jack CushHOST
1:05
That would be adults with PMR not responding to or intolerant of glucocorticoids.
Jack CushHOST
1:12
This makes secukinumab the first IL-17A inhibitor approved in Europe for PMR.
Greg PainGUEST
32:14
hardware.
Tim BeveridgeHOST
32:15
I've had two full knee replacements at 45 and 54 Hashimoto's since age 14 and diagnosed PMR.
Tim BeveridgeHOST
32:21
Crikey.
Tim BeveridgeHOST
32:22
What strength exercises would you recommend once past three months post-surgery? The bone health's overall, but definitely density and more autoimmune issues developing caused by thyroid hormones.
Greg PainGUEST
32:14
hardware.
Tim BeveridgeHOST
32:15
I've had two full knee replacements at 45 and 54 Hashimoto's since age 14 and diagnosed PMR.
Tim BeveridgeHOST
32:21
Crikey.
Tim BeveridgeHOST
32:22
What strength exercises would you recommend once past three months post-surgery? The bone health's overall, but definitely density and more autoimmune issues developing caused by thyroid hormones.
Andy McDonoughGUEST
5:35
You can get really instant feedback on your cases.
Andy McDonoughGUEST
5:37
So you think someone's got PMR.
Andy McDonoughGUEST
5:39
You think somebody's got an infection.
Andy McDonoughGUEST
5:40
You get your blood back in an hour, not in a week.
Clint PattisonHOST
55:26
Does this also work for
Jose PandoGUEST
55:27
PMR? Technically, it could be, but I don't think that there's other medications that you can use that are more easily accessible and less expensive.
Clint PattisonHOST
55:38
So would you, at the moment, just for now, would you consider this particularly implantable device something that is a last resort or something as a workaround when conventional treatment fails, rather than something that is going to be a first-line approach for anyone?
Jose PandoGUEST
56:01
Like, if you look at traditionally how things have worked, and we have been doing this for a long time, is that you use with your sicker patients, and when you feel more comfortable and see the response, and you say, oh my goodness, this can work better for this or that type of patients, you begin to use it more broadly.
Martin SmithGUEST
50:25
I was seriously ill.
Martin SmithGUEST
50:26
I had PMR and giant cell arteritis.
Martin SmithGUEST
50:28
My wife had had breast cancer.
Martin SmithGUEST
50:30
She had two hip operations that have gone completely wrong.
speaker_0HOST
9:22
How do you confirm the diagnosis of polyarteritis nodosa? Biopsy or angiogram.
speaker_0HOST
9:34
Polymyalgia rheumatica is strongly associated with which other type of vasculitis? Temporal arteritis or giant cell arteritis.
speaker_0HOST
9:51
Define CREST syndrome.
speaker_0HOST
10:01
Calcinosis, Raynaud's, esophageal dysmotility, sclerodactyly, and telangiectasia.

8 MINS LATER

speaker_0HOST
18:05
She also complains of fatigue and fever.
speaker_0HOST
18:08
Labs show a markedly elevated erythrocyte sedimentation rate.
speaker_0HOST
18:12
What is the most likely diagnosis? Polymyalgia rheumatica.
speaker_0HOST
18:24
What is the treatment for scleroderma? There is no specific treatment, but you can treat the individual symptoms.
Jack CushHOST
12:02
We have a bunch of reports on vasculitis and a report- a few reports on avacopan.
Jack CushHOST
12:07
Let's start with discussion of PMR, a Danish national study of fifty-one thousand PMR patients.
Jack CushHOST
12:15
Um, half managed by primary care, half managed by secondary care MDs, I would assume that's rheumatologists.
Jack CushHOST
12:23
The incidence of PMR is a hundred and twelve cases per hundred thousand.
Jack CushHOST
12:28
That seems to be on par.
Jack CushHOST
12:31
Um, but the incidence over time, they did this between, um, over the years, uh, ten-year ic- interval, um, between them.
Jack CushHOST
12:41
But the incidence of PMR in primary care went down, but increased in secondary care.
Jack CushHOST
12:47
Hmm.
Amanda MixonHOST
0:00
[intro music] Welcome to RapCast, the official podcast of Rheumatology Advanced Practice Providers, where we bring together expert perspectives, practical insights, and meaningful conversations shaping rheumatology care today.
Amanda MixonHOST
0:28
I'm Amanda Mixon, and I am very excited to welcome you to today's episode, "The Steroid Tightrope: Managing Glucocorticoid Toxicity in PMR." This podcast is a clinical review of current approaches to the treatment of polymyalgia rheumatica, inclusive of treat to target strategy, the value of leveraging treatment based on glucocorticoid use according to the guidelines, and elements that should be taken into consideration in patients that do not achieve treatment goals, such as control of signs and symptoms and remission.
Amanda MixonHOST
1:05
Glucocorticoids remain the cornerstone of treatment for polymyalgia rheumatica, often delivering a rapid and dramatic symptom relief for patients.
Amanda MixonHOST
1:15
Because of the trade-off between the benefits and challenges of steroid use, it's critical to balance the gain against the potential harms.
Amanda MixonHOST
1:24
About half of the patients diagnosed with PMR and treated with glucocorticoids do achieve clinical response within the time and dose framework defined in the current guidelines.
Amanda MixonHOST
1:36
However, as every rheumatology provider knows, that relief can come with a cost.
Amanda MixonHOST
1:42
Many patients struggle with prolonged steroid exposure, taper-related relapses, and the cumulative burden of glucocorticoid toxicity.
Amanda MixonHOST
1:51
This can be anything from metabolic and cardiovascular complications to osteoporosis, infection risk, and just overall impacts on the quality of life.

3 more episodes mention polymyalgia rheumatica.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.